Recent Press Releases

Award-Winning Actress S. Epatha Merkerson, Merck and the American Diabetes Association Challenge African Americans with Type 2 Diabetes to Get to Their A1C Goal

Merkerson Visits Raleigh on July 15 as Part of America's Diabetes Challenge: Get to Your Goals Program

KENILWORTH, N.J.,

SANOFI ANNOUNCES NEW, GLOBAL BUSINESS UNIT STRUCTURE TO DRIVE FUTURE GROWTH

Deepens specialization and allows clear focus on growth drivers Three, new Global Business Units for General Medicines & Emerging Markets, Specialty Care, and Diabetes & Cardiovascular...

Ardelyx to Provide Updates on Research and Development Programs at Today's Inaugural R&D Day in New York City

Tenapanor development plans will be presented along with new data demonstrating sustained response in IBS-C

FREMONT, Calif.,

Bayer receives European approval for Gadovist® (gadobutrol) for use in pediatric patients less than 2 years of age

Leverkusen, July 14, 2015 – Bayer HealthCare announced today that Gadovist® (gadobutrol) has received a label extension in the European Union (EU) for diagnostic use with magnetic resonance...

Consumer and Public Interest Groups Write To FTC Opposing Teva's Hostile Takeover of Mylan

Washington, D.C. – Today, consumer advocacy groups including Consumers Union, Consumer Federation of America, US PIRG, Consumer Action, Consumer Watchdog, Public Citizen, and National Center...

IRESSA APPROVED BY US FDA FOR FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED EGFR MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER

IRESSA APPROVED BY US FDA FOR FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED EGFR MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER 13 July 2015 AstraZeneca today announced that the US Food and Drug...

Cummings and Sanders Urge States to Combat Overcharging for Critical Drug Used by First Responders

For Immediate Release July 13, 2015 Contact Jennifer Werner (Cummings): 202-226-5181 Michael Briggs (Sanders): 202-224-5141 Cummings and Sanders Urge States to...

Mylan One of First to Launch Generic Version of Namenda(R) Tablets

Company awarded 180 days shared marketing exclusivity - HERTFORDSHIRE, England and PITTSBURGH, July 14, 2015 /PRNewswire/ -- Mylan N.V. (Nasdaq: MYL) today announced the U.S. launch of Memantine...

Johnson & Johnson Reports 2015 Second-Quarter Results

Sales of $17.8 Billion Decreased 8.8% Versus 2014 Second Quarter Second-Quarter EPS was $1.61 Adjusted 2015 Second-Quarter EPS of $1.71 Decreased 3.9%* Solid Underlying Growth Offset by Currency and...

GSK and the Francis Crick Institute join forces in collaboration to forge new scientific discoveries

The Francis Crick Institute, the UK's newest biomedical research facility, and GSK, the UK's largest pharmaceutical company, are to partner on an open innovation collaboration exploring new avenues...

NICE recommends edoxaban tosylate (Lixiana) for treating and preventing potentially fatal blood clots

In draft guidance published today NICE has recommended the anti-blood clotting drug edoxaban tosylate (Lixiana, Daiichi Sankyo) as an option for treating and preventing the recurrence of potentially...

Cummings and Sanders Urge States to Combat Overcharging for Critical Drug Used by First Responders

Washington, D.C.—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, and Senator Bernard Sanders, Ranking Member of the Subcommittee on...

EMA to further clarify safety profile of human papillomavirus (HPV) vaccines

The European Medicines Agency (EMA) has started a review of HPV vaccines to further clarify aspects of their safety profile. These vaccines have been used in around 72 million people worldwide and...

IMBRUVICA® (IBRUTINIB) NOW APPROVED TO TREAT WALDENSTROM'S MACROGLOBULINEMIA IN EUROPE

IMBRUVICA® (IBRUTINIB) NOW APPROVED TO TREAT WALDENSTROM'S MACROGLOBULINEMIA IN EUROPE SUNNYVALE, Calif., July 10, 2015 /PRNewswire/ -- Today AbbVie (NYSE: ABBV) announced the European...

AstraZeneca sharpens focus on main therapy areas through agreement with gastroenterology specialist Tillotts Pharma for Entocort

Thursday, 9 July 2015 AstraZeneca announced today that it has entered into an agreement with Tillotts Pharma AG (Tillotts), part of the Zeria Group, for the divestment of global rights, outside the...

Teva First to Receive Approval and Launch Generic Axert® Tablets in the United States

JERUSALEM--(BUSINESS WIRE)--Jul. 8, 2015-- Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced the launch of generic Axert® (almotriptan malate) tablets, 6.25 mg and 12.5 mg, in the...

The International Society of Aesthetic Plastic Surgery Releases Global Statistics on Cosmetic Procedures

Over 20 million cosmetic procedures were performed throughout the world in 2014

HANOVER, N.H., July 8, 2015

Allergan Enters Into Licensing Agreement with Merck to Obtain Exclusive Worldwide Rights to CGRP Migraine Development Program

-- Small-Molecule Program Includes Commercial Opportunities For the Treatment and Prevention of Migraine --

DUBLIN and

Depomed Confirms Receipt of Unsolicited Proposal from Horizon Pharma plc

Board Previously Reviewed and Rejected Identical Highly Conditional, Unsolicited Proposal NEWARK, Calif., July 7, 2015 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) ("Depomed" or the...